Khat use and mental illness: A critical review

Social Science and Medicine

Volumn 65, Issue 2, 2007, Pages 309-318

  Warfa, Nasir ^a   Klein, Axel ^b   Bhui, Kamaldeep ^a   Leavey, Gerard ^c   Craig, Tom ^d   Alfred Stansfeld, Stephen ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cross cultural measurements; Drugs classification system; Harm reduction; Khat use; Mental illness; Moral panic

Indexed keywords

EVERGREEN TREE; HEALTH IMPACT; HEALTH WORKER; LAW ENFORCEMENT; MENTAL HEALTH; MORALITY; POLICY MAKING;

ARTICLE; CATHA EDULIS; DRUG CLASSIFICATION; HEALTH CARE PERSONNEL; HUMAN; MENTAL DISEASE; RELIABILITY; SOCIAL ASPECT; UNITED KINGDOM; VALIDITY;

CATHA; GREAT BRITAIN; HUMANS; MENTAL DISORDERS;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

CATHA EDULIS;

EID: 34250359942     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2007.04.038     Document Type: Article

References (54)

1. Advisory Council on the Misuse of Drugs. (2005). Khat (Qat): Assessment of risk to the individual and communities in the UK. 〈〉.
2. Ahmed A.G., and Salib E. The Khat users: A study of khat chewing in Liverpool's Somali men. Medicine, Science and Law 38 2 (1998) 165-169
3. Alem A., Kebede D., and Kullgren G. The prevalence and socio-demographic correlates of khat chewing in Butajira, Ethiopia. Acta Psychiatrica Scandinavica 100 (1999) 84-91
4. Alem A., and Shibre T. Khat induced psychosis and its medico-legal implication: A case report. Ethiopian Medical Journal 35 (1997) 137-141
5. Al-Motarreb A., Baker K., and Broadley K.J. Khat: Pharmacological and medical aspects and its social use in Yemen. Phytotherapy Research 16 (2002) 403-413
6. Anderson D., Beckerleg S., Hailu D., and Klein A. The Khat controversy: Stimulating the debate on drugs (cultures of consumption) (2007), Berg Publishers, London
7. Arseneault L., Cannon M., Witton J., and Murray R. Cannabis as a potential causal factor in schizophrenia. In: Castle D., and Murray R. (Eds). Marijuana and madness: Psychiatry and neurobiology (2004), Cambridge University Press, Cambridge
8. Balint G.A., Ghebrekidan H., and Balint E.E. Catha edulis, an international socio-medical problem with considerable pharmacological implications. East African Medical Journal 68 7 (1991) 555-561
9. Bhui K., Craig T., Mohamud S., Warfa N., Stansfeld, et al. Mental disorders among Somali refugees: Developing culturally appropriate measures and assessing socio-cultural factors. Social Psychiatry and Psychiatric Epidemiology xx (2006) 1-9
10. Bhui K., Mohamud S., Warfa N., Craig T., and Stansfeld S. Cultural adaptation of mental health measures: Improving the quality of clinical practice and research. British Journal of Psychiatry 183 (2003) 184-186
11. Brooke C. 'Khat (Cathe Edulis): Its production and trade in the Middle East'. The Geographical Journal 126 1 (1960) 52-59
12. Carlini E.A. Plants and the central nervous system. Pharmacology, Biochemistry and Behaviour 75 3 (2003) 501-512
13. Carothers J.C. Miraa as a cause of insanity. The East African Medical Journal (1945) 4-6
14. Cohen S. Folk devils and moral panics (1972), MacGibbon and Kee, London
15. Critchlow S., and Seifert R. Khat induced paranoid psychosis. British Journal of Psychiatry 150 (1987) 246-247
16. Dhadphale M., and Omolo O.E. Psychiatric morbidity among khat chewers. East African Medical Journal 65 6 (1988) 355-359
17. Drake P.H. Khat chewing in the near East. Lancet 1 8584 (1988) 532-533
18. Elmi A., Ahmed Y.H., and Samatar M.S. Experience in the control of khat: Chewing in Somalia. Bulletin of Narcotics 39 2 (1987) 51-57
19. Elmi A.S. The chewing of khat in Somalia. Journal of Ethnopharmology 8 2 (1983) 163-176
20. Flaherty J.A., Gaviria F.M., Pathak D., Mitchell T., Wintrob R., Richman J.A., et al. Developing instruments for cross-cultural mental research. The Journal of Nervous and Mental Disease 176 5 (1988) 257-263
21. Giannini A.J., and Castellani S. A manic-like psychosis due to khat (Catha edulis forsk). Journal of Toxicology-Clinical Toxicology 19 5 (1982) 455-459
22. Gough S.P., and Cookson I.P. Khat-induced schizophreniform psychosis in UK. The Lancet 1 (1984) 455
23. Granek M., Shalev A., and Weingarten A.M. Khat-induced hypnagogic hallucinations. Acta Psychiatrica Scandinavica 78 (1988) 458-461
24. Griffiths P., Gossop M., Wickenden S., Dunworth J., Harris K., and Lloyd C. Transcultural pattern of drug use: Qat (khat) in the UK. British Journal of Psychiatry 170 3 (1997) 281-284
25. Halbach H. Medical aspects of the chewing of khat leaves. Bulletin of World Health Organisation 47 (1972) 21-29
26. Hassan N.A., Gunaid A.A., El-Khally F.M., and Murray-Lyon I. The effect of chewing khat leaves on human mood. Saudi Medical Journal 23 7 (2002) 850-853
27. House of Commons' Hansard Debates. (1996). Crime and disorder bill, column 1306.
28. House of Commons' Hansard Debates. (1998). Crime and disorder bill, column 17.
29. House of Commons' Hansard Debates. (2005). Drugs bill, column 532.
30. Jager A.D., and Sireling L. Natural history of khat psychosis. Australian and New Zealand Journal of Psychiatry 28 (1994) 331-332
31. Johanson C.E., and Schuster C.R. A comparison of the behavioural effects of 1-and 1-Cathione and d-amphetamine. Journal of Pharmacology and Experimental Therapeutics (1981) 255-262
32. Kassim S., and Croucher R. Khat Chewing amongst UK resident male Yemeni adults: An exploratory study. International Dental Journal 56 (2006) 97-101
33. Kennedy J., Tegue J., Rokaw W., and Cooney E. The medical evaluation of the use of qat in North Yemen. Social Science & Medicine 17 12 (1983) 783-793
34. Knudsen H.C., Vazquez-Barquero J.L., Welcher B., Gaite L., Becker T., Chisholm D., et al. Translation and cross-cultural adaptation of outcome measurements for schizophrenia. EPSILON Study 2. British Journal Psychiatry 177 Suppl 39 (2000) s8-s14
35. Lewin L. Phantastica, narcotic and stimulating drugs (1931), Routledge and Kegan Paul, London
36. Litman A., Saltz-Rennert H., and Maoz B. The use of Khat. Culture, Medicine and Psychiatry 10 (1986) 386-389
37. Luqman W., and Danowski T.S. The use of khat (Catha edulis) in Yemen social and medical observations. Annals of Internal Medicine 85 (1976) 246-249
38. McCrone P., Bhui K., Craig T., Mohamud S., Warfa N., Stansfeld S.A., et al. Mental health needs, service use and costs among Somali refugees in the UK. Acta Psychiatrica Scandinavica 111 5 (2005) 351-357
39. McLaren P. Khat psychosis. British Journal of Psychiatry 150 (1987) 712-725
40. Nencini P., and Ahmed A.M. Khat consumption: A pharmacological review. Drug and Alcohol Dependence 23 (1989) 19-29
41. Nencini P., Anania M.C., Ahmed A.M., Amiconi G., and Elmi A.S. Physiological and neuroendocrine effects of Khat in man. In: Shahander B., Geadah R., Tongue A., and Rolil J. (Eds). International conference on Khat, proceedings (1983), International Council on Alcohol and Addiction, Lausanne, Switzerland 148-152
42. Nencini P., Grassi M.C., Botan A.A., Asseyr A.F., and Paroli E. Khat chewing spread to the Somali community in Rome. Drug and Alcohol Dependence 23 (1989) 255-258
43. Nielen R.J., van der Heijden F.M.M.A., Tuinier S., and Verhoeven W.M.A. Khat and mushrooms associated with psychosis. World Journal of Biological Psychiatry 5 (2004) 49-53
44. Numan N. Exploration of adverse psychological symptoms in Yemeni khat users by the Symptoms Checklist-90 (SCL-90). Addiction 99 (2004) 61-65
45. Odenwald M., Neuner F., Schauer M., Elbert T., Catani C., Lingenfelder B., et al. Khat use as risk factor for psychotic disorders: A cross-sectional and case-control study in Somalia. BMC Medicine 3 5 (2005) 1741-7015 3-5
46. Pantelis C., Hindler C.G., and Taylor J.C. Use and abuse of khat (Catha edulis): A review of the distribution, pharmacology, side effects and a description of psychosis attributed to khat chewing. Psychological Medicine 19 (1989) 657-668
47. Patel N.B. Mechanism of action of Cathinone: the active ingredient of khat (Catha edulis). East African Medical Journal 77 11 (2000) 592-595
48. Stefan J., and Mathew B. Khat chewing: An emerging drug concern. Australian and New Zealand Journal of Psychiatry 39 9 (2005) 842-843
49. Toennes S.W., Harder S., Schramm M., Niess C., and Kauert G.F. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. British Journal of Pharmacology 56 1 (2003) 125-130
50. Yousef G., Huq Z., and Lambert T. Khat chewing as a cause of psychosis. British Journal of Hospital Medicine 54 7 (1995) 322-326
51. Warfa N., Bhui K., Craig T., Mohamud S., Stansfeld S., McCrone T., et al. Post-migration residential mobility, mental health and health service utilization among Somali refugees in the UK: A qualitative study. Health and Place 12 (2006) 503-515
52. Warfa N., Bhui K., Phillips K., Nandy K., and Griffiths S. Comparison of life events, substance misuse, service use and mental illness among African-Caribbean, Black African, and White British men in East London: A qualitative study. Diversity in Health and Social Care 3 (2006) 111-121
53. World Health Organisation Advisory Group. Review of the pharmacology of khat. Bulletin on Narcotics XXXII (1980) 3
54. US Food and Drug Administration. (1994). International Drug Scheduling, 94N-0173.